←Back to Expert Scholars
Translational Medicine / 转化医学HER2 NSCLC, Thoracic Oncology
Federico Cappuzzo
MD
🏢Regina Elena National Cancer Institute🌐Italy
Director, Medical Oncology
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Federico Cappuzzo is an internationally recognized Italian thoracic oncologist who has contributed to major NSCLC trials including HER2 targeted therapy studies. He has long examined HER2 amplification and overexpression as biomarkers in lung cancer. He leads national thoracic oncology initiatives in Italy.
Share:
🧪Research Fields 研究领域
HER2 NSCLC
EGFR
thoracic oncology
Italian trials
precision therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Federico Cappuzzo 的研究动态
Follow Federico Cappuzzo's research updates
留下邮箱，当我们发布与 Federico Cappuzzo（Regina Elena National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment